TB, again becoming a major threat to public health, is "one more opportunistic infection" that contributes to the fatalities of AIDS patients, says Craig A. Rosen, the department chairman for gene regulation at the Roche Institute of Molecular Biology in Nutley, N.J., and head of AmFAR's Scientific Advisory Committee.
Bernard A. Dempsey, Jr., AmFAR's grants officer in Los Angeles, says that the foundation is currently preparing a request for proposals focusing on diagnostic tests and studies of multi-drug-resistant strains of TB. He says that $300,000 in grant money will be made available through this new TB program.
The TB research effort represents the latest example of AmFAR's mission to act as a "catalyst" to get new AIDS-related research "off the ground" and "stop the virus in its track," according to the foundation's president, Mervyn F. Silverman, a physician who holds faculty positions at the University of California, San Francisco, and ...
